Immediate Impact
4 from Science/Nature 70 standout
Citing Papers
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2024 Standout
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
2023 Standout
Works of Suying Li being referenced
Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Suying Li | 1905 | 855 | 502 | 139 | 3.9k | |
| William McClellan | 1601 | 716 | 416 | 77 | 3.6k | |
| Abhijit V. Kshirsagar | 1215 | 732 | 241 | 124 | 3.7k | |
| Ho Jun Chin | 1827 | 621 | 396 | 187 | 3.9k | |
| Jason Oke | 1391 | 495 | 478 | 92 | 4.0k | |
| Guillermo García-García | 2871 | 590 | 510 | 150 | 5.5k | |
| Austin G. Stack | 3049 | 884 | 316 | 79 | 4.2k | |
| Jiannong Liu | 1903 | 498 | 381 | 89 | 3.6k | |
| Dana C. Miskulin | 2350 | 622 | 261 | 91 | 4.3k | |
| Jerry Yee | 1919 | 819 | 575 | 134 | 4.7k | |
| Luxia Zhang | 2294 | 1214 | 731 | 196 | 5.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...